PlainRecalls
FDA Drug Moderate Class II Terminated

Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India NDC 33342-054-07

Reported: October 23, 2019 Initiated: September 23, 2019 #D-0140-2020

Product Description

Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India NDC 33342-054-07

Reason for Recall

Superpotent

Details

Recalling Firm
Macleods Pharma Usa Inc
Units Affected
31,968 bottles
Distribution
Product was shipped to 8 distributors who may have further distributed the product.
Location
Plainsboro, NJ

Frequently Asked Questions

What product was recalled?
Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India NDC 33342-054-07. Recalled by Macleods Pharma Usa Inc. Units affected: 31,968 bottles.
Why was this product recalled?
Superpotent
Which agency issued this recall?
This recall was issued by the FDA Drug on October 23, 2019. Severity: Moderate. Recall number: D-0140-2020.